(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...
Jul 25, 2014
5 / 5 (1) | 0
(Medical Xpress)—Researchers at the University of Liverpool have taken a major step forward in understanding the causes of a disorder which causes chronic pain in sufferers.
Jun 30, 2014
4 / 5 (1) | 0